FIELD: chemistry.SUBSTANCE: invention relates to novel carboxyl- or hydroxyl-substituted benzimidazole derivatives of formula (I), or pharmaceutically acceptable salts thereof, where R1 is selected from and , R2 is hydrogen； R3 is cyclohexyl or bicyclo[2.2.1]heptyl； R4 is phenyl, which is substituted in the 4th position with a halogen or a lower fluoroalkyl, or a pyridyl, which is substituted with 1 or 2 substitutes independently selected from halogen and a lower alkoxy group； R5 and R6 independently denote hydrogen or fluorine； R7 and R9 are independently selected from a group consisting of hydrogen, lower alkyl, halogen, lower alkoxy group, lower fluoroalkyl, lower fluoroalkoxy group and cyano group； R8 is -(CR12R13)n-COOH, where n equals 0, 1 or 2, and R12 and R13 are independently hydrogen or lower alkyl, or -O-(CR14R15)p-COOH, where p equals 1 or 2, and R14 and R15 are independently hydrogen or lower alkyl, or R14 and R15 together with the carbon atom with which they are bonded form a cycloalkyl ring, or R8 is tetrazole； R10 is a hydroxy group or -(CH2)p-COOH, where p equals 0 or 1； m equals 0 or 1； R11 is -COOH. The invention also relates to specific carboxyl- or hydroxyl-substituted benzimidazole derivatives and a pharmaceutical composition based on a compound of formula (I).EFFECT: novel carboxyl- or hydroxyl-substituted benzimidazole derivatives, having selective activity with respect to farnesoid X receptor, are obtained.26 cl, 126 exНастоящее изобретение относится к новым карбоксил- или гидроксилзамещенным бензимидазольным производным формулы (I), или к их фармацевтически приемлемым солям, где R1 выбран из, и и R2 представляет собой водород； R3 представляет собой циклогексил или бицикло[2.2.1]гептил； R4 представляет собой фенил, который замещен в 4-положении галогеном или фторнизшим алкилом, или пиридил, который замещен 1 или 2 заместителями, независимо выбранными из галогена и низшей алкоксигруппы； R5 и R6 независимо друг от друга представляют собо
